Home

Evan Lippman, EVP, Business Development: Teva Pharmaceutical Industries TEVA Sell · Filed 05/18

Trade details

Type
Insider sale
Amount
$1,277,748.96
Shares · price
35,912 sh · $35.58 a share
Held after
44,191 sh
Trade date
26/05/14
Filed
26/05/18
Days to filing
4 days

Sold 44.8% of holdings

Share of holding sold
44.8%

Teva Pharmaceutical Industries trades, last 26 weeks

What else happened in Teva Pharmaceutical Industries around then

Filed or reported within 30 days of the trade day · 04/14~06/13

Evan Lippman's recent trades

  • Evan Lippman

    Planned sale10b5-1 planTeva Pharmaceutical Industries

    $680.3K

    Filed 08/17

  • Evan Lippman

    Sell10b5-1 planTeva Pharmaceutical Industries

    $204.4K

    Filed 05/18

  • Evan Lippman

    Planned sale10b5-1 planTeva Pharmaceutical Industries

    $1.5M

    Filed 05/14